Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homeodomain Proteins | 3 | 2016 | 157 | 0.680 |
Why?
|
| NF-kappa B | 2 | 2007 | 432 | 0.510 |
Why?
|
| eIF-2 Kinase | 4 | 2011 | 49 | 0.450 |
Why?
|
| Heparin | 2 | 2005 | 205 | 0.430 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2005 | 317 | 0.400 |
Why?
|
| Umbilical Veins | 1 | 2007 | 54 | 0.300 |
Why?
|
| Endothelial Cells | 2 | 2007 | 384 | 0.290 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 33 | 0.210 |
Why?
|
| Inflammation | 1 | 2007 | 1030 | 0.190 |
Why?
|
| Cell Proliferation | 1 | 2005 | 1174 | 0.180 |
Why?
|
| Tropomyosin | 1 | 2016 | 4 | 0.140 |
Why?
|
| Clubfoot | 1 | 2016 | 6 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 627 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2011 | 215 | 0.100 |
Why?
|
| Transfection | 2 | 2016 | 782 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 615 | 0.090 |
Why?
|
| Viral Proteins | 1 | 2011 | 150 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2673 | 0.090 |
Why?
|
| HIV-1 | 1 | 2011 | 177 | 0.090 |
Why?
|
| Tunicamycin | 1 | 2008 | 10 | 0.080 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 47 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 45 | 0.070 |
Why?
|
| E-Selectin | 1 | 2007 | 44 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 52 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2007 | 117 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 282 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 226 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 337 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2007 | 447 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 659 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2008 | 597 | 0.060 |
Why?
|
| Cyclin A | 1 | 2005 | 11 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 682 | 0.060 |
Why?
|
| Protein Binding | 3 | 2016 | 1027 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2005 | 38 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 626 | 0.060 |
Why?
|
| Mitosis | 1 | 2005 | 76 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 97 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2005 | 144 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 194 | 0.060 |
Why?
|
| Cell Line | 3 | 2016 | 1752 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 230 | 0.050 |
Why?
|
| Apoptosis | 1 | 2008 | 1641 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 541 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2002 | 312 | 0.050 |
Why?
|
| Aorta | 1 | 2002 | 316 | 0.050 |
Why?
|
| Binding Sites | 2 | 2016 | 631 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2011 | 28 | 0.040 |
Why?
|
| Humans | 6 | 2016 | 68618 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2011 | 237 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2011 | 1200 | 0.040 |
Why?
|
| Rats | 1 | 2005 | 5300 | 0.030 |
Why?
|
| Animals | 3 | 2016 | 20881 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 60 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 52 | 0.030 |
Why?
|
| Luciferases | 1 | 2016 | 105 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 103 | 0.030 |
Why?
|
| Haplotypes | 1 | 2016 | 174 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 207 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 191 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 144 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 947 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 786 | 0.030 |
Why?
|
| DNA Primers | 1 | 2011 | 302 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 8474 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1293 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 1015 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 791 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2008 | 36 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2007 | 13 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2007 | 67 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 322 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 5731 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1083 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1447 | 0.020 |
Why?
|